Status:
COMPLETED
Deep Sclerectomy vs Xen in Solo Procedure
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
Glaucoma is the leading cause of irreversible blindness in the world and the second leading cause of blindness after cataract after the age of 50. Lowering intraocular pressure (IOP) is the only treat...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with primary or secondary open angle glaucoma
- Patient who has undergone a SPNP or XEN procedure in solo
- French speaking patient
Exclusion
- Angle closure
- Less than 6 months follow-up
- History of eye filtering surgery included
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Patient objecting to the use of his/her data for this research
Key Trial Info
Start Date :
July 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2022
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT05201378
Start Date
July 15 2021
End Date
October 6 2022
Last Update
April 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014